Discover Startup Events Near Me 

Ozette raises $6 million for immune system-monitoring tech

Ozette, a Seattle, Washington-based life sciences startup, today announced that it raised $6 million in seed funding from Madrona Venture Group and the Allen Institute for AI (AI2). Ozette, a spinout founded in 2020 and incubated at AI2, aims to build an immune monitoring platform powered by technologies developed at the Fred Hutch. According to Ansary, Ozette provides a view of single-cell data while automatically delivering results and reproducible experiments, agnostic of instrumentations.a“Think of the Ozette [platform] like an MRI for the immune system,” Ansary explained. Immunai, a company developing a proprietary corpus of immune-centric human tissue analyses, recently emerged from stealth with $20 million in funding. Ozette plans to continue supporting the open-source Cytoverse community, which relies on tooling developed by the company’s team, while developing the immune monitoring platform.

Startup Around is now on Telegram and Whatsapp. For the best startup stories & resources, subscribe us on Telegram & Whatsapp.